<DOC>
	<DOCNO>NCT00764244</DOCNO>
	<brief_summary>Macular edema main cause vision loss diabetic patient . Its treatment mainly base laser photocoagulation , limited result . Alternative treatment investigation , vitrectomy intravitreal injection triamcinolone .The aim VITRILASE compare efficacy two treatment laser photocoagulation diabetic macular edema .</brief_summary>
	<brief_title>Laser Versus Vitrectomy Versus Intravitreal Triamcinolone Injection Diabetic Macular Edema</brief_title>
	<detailed_description>It randomize study three arm - vitrectomy - repeat intravitreal triamcinolone injection - laser photocoagulation</detailed_description>
	<mesh_term>Macular Edema</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Triamcinolone hexacetonide</mesh_term>
	<mesh_term>Triamcinolone</mesh_term>
	<mesh_term>Triamcinolone Acetonide</mesh_term>
	<mesh_term>Triamcinolone diacetate</mesh_term>
	<criteria>1 . Patient type 1 type 2 diabetes 2 . Visual acuity ( VA ) : 0.1≤ VA &lt; 0.5 ( 35 ≤ ETDRS score &lt; 70 ) 3 . Patient diffuse diabetic macular edema , define : § Retinal thickening involve center macular biomicroscopy§ AND diffuse leakage fluorescein angiography . 4 . Macular thickness central area 1000 µm diameter ³ 300 µm . 5 . Patient : · Either diffuse diabetic macular edema · Or combine diffuse focal diabetic macular edema persistent diffuse macular edema 6 month laser treatment focal edema . 6 . Systolic blood pressure ≤ 160 mmHg diastolic blood pressure ≤ 90 mmHg. , 7 . HbA1c &lt; 10 % . 1 . Patient tractional diabetic macular edema , define by· A taut , thicken posterior hyaloid biomicroscopy AND/OR· thicken , highly reflective posterior hyaloid OCT , partially detach posterior pole , exert traction macula 2 . Active proliferative diabetic retinopathy ( ETDRS stage 61 severe ) 3 . Structural damage center macula study eye likely preclude improvement visual acuity follow resolution macular edema , include atrophy retinal pigment epithelium , subretinal fibrosis , laser scar ( ) , organize central hard exudate plaque³ 1 disk area 4 . Hypertensive retinopathy 5 . Epiretinal membrane . 6 . Rubeosis iris . 7 . Patient require immediate panretinal photocoagulation panretinal photocoagulation perform within past 6 month . 8 . History chronic glaucoma study eye 9 . History elevate intraocular pressure ≥30 mm Hg and/or alteration visual field 10 . Concomitant therapy systemic topical ocular corticosteroid within last 15 day . 11 . Cataract surgery study eye within past 6 month , YttriumAluminumGarnet ( YAG ) laser capsulotomy within past 6 month , 12 . Aphakia 13 . Patient pseudophakic macula edema 14 . Unstable medical status include glycemic control blood pressure . Patients poor glycemic control , within last 4 month , initiate intensive insulin treatment ( pump multiple daily injection ) enrol . 15 . Chronic renal failure 16 . Pregnant nursing ( lactate ) woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Diabetes</keyword>
	<keyword>Macular edema</keyword>
	<keyword>Optical Coherence tomography</keyword>
	<keyword>VitrectomyLaser therapy</keyword>
	<keyword>Intravitreal triamcinolone injection</keyword>
</DOC>